Executive Insights: State and Future of the Orthopedic Industry

About Webinar

Orthopedics faces an unprecedented moment as companies juggle commercializing products alongside their COVID-19 response. We assembled executives from companies of all sizes and across orthopedic market segments to discuss critical topics, including:

• COVID: What is the expected recovery timeline? How has the industry changed?
• Technology: What role will digital and enabling technology play?
• ASCs: Which procedures will shift away from the hospital setting and when?
• M&A: What’s driving today’s acquisition and divestiture environment?

About speaker/s

Lawrence Biegelsen, Senior Medical Device Equity Research Analyst, Wells Fargo

Larry Biegelsen is a sell side equity research analyst covering medical supplies and devices. His 14 years at Wells Fargo were preceded by five years at Prudential Securities.

Jacob Paul, SVP, President, Cranial and Spinal Technologies, Medtronic

Mr. Paul’s career at Medtronic began in 2002 as Director of Finance. Subsequent titles included Vice President Finance, Strategy, Emerging Markets; Vice President Restorative Therapy Group, Asia Pacific and Senior Vice President & President, Spine and Biologics before his current position, which he assumed in 2020.

Albert DaCosta, President and CEO, Paragon 28

Albert DaCosta has over 15 years of experience in the Foot & Ankle marketplace. Prior to establishing Paragon 28, Albert was a distributor for both Pioneer Surgical and Biomet Sports Medicine with responsibility spanning 12 states. Mr. DaCosta served as the Director of Biologics & Extremities for Wright Medical. He also served as President of Non-Invasive Solutions, a company focused on lithotripsy for plantar fasciitis and lateral epicondylitis.

Benny Hagag, President, MicroPort Orthopedics 

Mr. Hagag is an highly experienced medical device executive, with over 25 years leading a multitude of business functions with a deep background in R&D and business development. Mr. Hagag was a co-founder of MAKO Surgical Group. He joined Stryker following its acquisition of MAKO in 2013 as the International General Manager and Vice President for the MAKO robotic business and then served as General Manager and Vice President for Stryker Asia Pacific for the MAKO business.

No matter your station in the orthopedic commercialization chain — engineer, executive, buyer, surgeon, investor, inventor, manufacturer — OMTEC is your resource.